Abstracts Poster Abstracts - Dr Falk

More documents

Recommendations

Info

Pancreatic carcinomaChair:W.E. Schmidt, BochumB. Wiedenmann, BerlinGenetics of chronic pancreatitis and pancreaticcarcinomaM.M. Lerch, Greifswald 31 - 34Surveillance and diagnostics of chronic pancreatitisJ. Mössner, Leipzig 35 - 36Diagnostics of pancreatic carcinomaJ. Ricke, Berlin (No abstract available)Medical management of pancreatic carcinomaJ.-M. Löhr, Mannheim 37Pancreatic cancer: Surgery, palliative resection andvalue of lymph node resectionH. Friess, Heidelberg 38 - 39Special Lecture IIIDevelopment compounds with different modes of actionfor the treatment of pancreatic and hepatocellular carcinomas:ZK 304709 and L19-IL2K. Bosslet, Berlin 40 - 41Special Lecture IVHow does pancreatic cancer develop?R.M. Schmid, Munich 42Special Lecture VChair:P.R. Galle, MainzG.J. Gores, RochesterAnti-apoptotic interventions as a novel treatmentoption in liver diseasesG.J. Gores, Rochester 434
Session Liver IDiagnosis and surveillance in liver diseaseChair:A.W. Lohse, HamburgG. Ramadori, GöttingenDiagnosis, primary and secondary prevention ofhepatocellular carcinomaJ.M. Llovet, New York 47Imaging modalitiesR. Lencioni, Pisa 48Role of pathology in neoplastic liver diseaseP. Schirmacher, Heidelberg 49Session Liver IIMetabolic liver diseaseChair:H.E. Blum, FreiburgW.E. Fleig, HalleFat, diabetes and liver injuryV. Ratziu, Paris 53The role of insulin resistance and extra-hepaticsignaling in fatty liverA.M. Diehl, Durham 54Steatosis and hepatitis C - does it matter?C.P. Day, Newcastle upon Tyne 55 - 57Hereditary hemochromatosis: The genes and the diseaseA. Pietrangelo, Modena 58 - 59Wilson disease: The impact of molecular advancesD.W. Cox, Edmonton 605
Page 1 and 2: BERLINAbstractsPoster AbstractsGAST
Page 3: CONTENTSpageCholelithiasis and bili
Page 7 and 8: Poster Abstracts1. Autoimmune pancr
Page 9 and 10: 24. Liver vascular index in NASH, c
Page 11 and 12: 47. Expression of claudins in human
Page 13 and 14: 67. Prevalence and association with
Page 15 and 16: 90. Ursofalk ® in cholestatic live
Page 17 and 18: 112. Agrin accumulates in the liver
Page 19: Molecular mechanisms controlling bi
Page 22 and 23: Etiology and pathogenesis of biliar
Page 25 and 26: Special Lecture IFuture development
Page 27 and 28: Pancreatic carcinoma
Page 29 and 30: 3. One pancreatic cancer case with
Page 31 and 32: However, the Melanoma Genetics Cons
Page 33 and 34: the pancreas encouraging duodenum p
Page 35 and 36: Pancreatic cancer: Surgery, palliat
Page 37 and 38: Special Lecture IIIDevelopment comp
Page 39 and 40: Special Lecture IVHow does pancreat
Page 41 and 42: Session Liver IDiagnosis and survei
Page 43 and 44: Imaging modalitiesProf. Riccardo Le
Page 45 and 46: Session Liver IIMetabolic liver dis
Page 47 and 48: The role of insulin resistance and
Page 49 and 50: other adipocyte-derived factors, in
Page 51 and 52: Hereditary hemochromatosis: The gen
Page 53 and 54: Wilson disease: The impact of molec
Page 55 and 56:
Immune pathogenesis of hepatitis B
Page 57 and 58:
However, neither WHV DNA nor WHsAg
Page 59 and 60:
The well established antiviral ther
Page 61 and 62:
Genomics of hepatocellular carcinom
Page 63 and 64:
A prospective study of more than 22
Page 65 and 66:
treatment approach with HDACi toget
Page 67 and 68:
statistically significant differenc
Page 69 and 70:
Prof. Dr. H. FriessAllgemein-/Visze
Page 71 and 72:
Prof. Dr. W.E. SchmidtInnere Medizi
Page 73 and 74:
Autoimmune pancreatitis: An underdi
Page 75 and 76:
Non-invasive parameters for predict
Page 77 and 78:
Table 1Agegroups1986-1991m-w1992-19
Page 79 and 80:
NTCP-mediated bile acid transport i
Page 81 and 82:
8The use of Ursofalk ® in patients
Page 83 and 84:
10High expression of agrin in hepat
Page 85 and 86:
12Chronic liver diseases associated
Page 87 and 88:
14Determination of hepatitis Delta
Page 89 and 90:
16Different expressions of claudins
Page 91 and 92:
For most of the morphological, hist
Page 93 and 94:
19Clinical and diagnostic value of
Page 95 and 96:
The impact of steatosis in fibrosis
Page 97 and 98:
23Unusual association between liver
Page 99 and 100:
25Effect of molsidomine and sin-1 o
Page 101 and 102:
27Concentration of antioxidative vi
Page 103 and 104:
29An assessment of cardiovascular m
Page 105 and 106:
Conclusions:1. Hepatic stellate cel
Page 107 and 108:
32Heme oxygenase-1 over-expression
Page 109 and 110:
34Autoimmune processes and alpha-in
Page 111 and 112:
36Therapy in non-alcoholic steatohe
Page 113 and 114:
38A case of hepatocellular carcinom
Page 115 and 116:
40Antigen-presenting cells in small
Page 117 and 118:
42Spatial complexity analysis of th
Page 119 and 120:
Endocrine cells in the large bile d
Page 121 and 122:
46Clinical features associated with
Page 123 and 124:
48Effect of losartan on early liver
Page 125:
50Assessment of histological featur
Page 128 and 129:
53Non-alcoholic fatty liver disease
Page 130 and 131:
55Helicobacter pylori infection and
Page 132 and 133:
57Mild to moderate autonomic dysfun
Page 134 and 135:
58Level of some proinflammatory cyt
Page 136 and 137:
60Port-site metastasis after laparo
Page 138 and 139:
62The influence of active prophylax
Page 140 and 141:
63Progressive familiar intrahepatic
Page 142 and 143:
65The survival rate among the Slova
Page 144 and 145:
66ILEI, a novel key component and r
Page 146 and 147:
68Clinical and pathological signifi
Page 148 and 149:
70High expression of claudin-7 duri
Page 150 and 151:
72Microhemorrheological disturbance
Page 152 and 153:
74High level of vitamin C in rat li
Page 154 and 155:
76Epidemiological analysis of HBV,
Page 156 and 157:
78Evaluation of Ursofalk ® 's effe
Page 158 and 159:
80Is the corticotherapy of malignan
Page 160 and 161:
82Transdifferentiation of hepatocyt
Page 162 and 163:
84The study of risk groups for chol
Page 164 and 165:
86Thrombocytosis as a prognostic fa
Page 166 and 167:
88Assessment of Helicobacter genus
Page 168 and 169:
90Ursofalk ® in cholestatic liver
Page 170 and 171:
92Activated hepatic stellate cells
Page 172 and 173:
94What is the actual prevalence of
Page 174 and 175:
96Hepatectomy for huge HCCJing-An R
Page 176 and 177:
98Increased expression of geranylge
Page 178 and 179:
100Helicobacter pylori eradication
Page 180 and 181:
102Treatment of pediatric metabolic
Page 182 and 183:
103A 5-years single center experien
Page 184 and 185:
104Tissue factor expression in inte
Page 186 and 187:
106Expression of matrilin-2 in live
Page 188 and 189:
108The significance of immunohistoc
Page 190 and 191:
110Hepatocellular carcinoma in pati
Page 192 and 193:
112Agrin accumulates in the liver d
Page 194 and 195:
114Prophylaxis of encephalopathy in
Page 196 and 197:
115Metadoxine modifies both apoptot
Page 198 and 199:
117Expression of the xenobiotic- an
Page 200 and 201:
Discussion/Conclusion: Compared wit
Page 202 and 203:
120Functional and morphological inj
Page 204 and 205:
Author Index to Poster Abstracts(Na
Page 206 and 207:
Guizzetti, M. 102Gulubova, M.V. 44,
Page 208 and 209:
Pascu, O. 94Páska, C. 10, 47, 106P
show all

Abstracts Poster Abstracts - Dr Falk

Create successful ePaper yourself

Delete template?

Save as template?